Literature DB >> 9686182

The role of T cell subsets and cytokines in the regulation of intracellular bacterial infection.

S C Oliveira1, J S Harms, E L Rech, R S Rodarte, A L Bocca, A M Goes, G A Splitter.   

Abstract

Cellular immune responses are a critical part of the host's defense against intracellular bacterial infections. Immunity to Brucella abortus crucially depends on antigen-specific T cell-mediated activation of macrophages, which are the major effectors of cell-mediated killing of this organism. T lymphocytes that proliferate in response to B. abortus were characterized for phenotype and cytokine activity. Human, murine, and bovine T lymphocytes exhibited a type 1 cytokine profile, suggesting an analogous immune response in these different hosts. In vivo protection afforded by a particular cell type is dependent on the antigen presented and the mechanism of antigen presentation. Studies using MHC class I and class II knockout mice infected with B. abortus have demonstrated that protective immunity to brucellosis is especially dependent on CD8+ T cells. To target MHC class I presentation we transfected ex vivo a murine macrophage cell line with B. abortus genes and adoptively transferred them to BALB/c mice. These transgenic macrophage clones induced partial protection in mice against experimental brucellosis. Knowing the cells required for protection, vaccines can be designed to activate the protective T cell subset. Lastly, as a new strategy for priming a specific class I-restricted T cell response in vivo, we used genetic immunization by particle bombardment-mediated gene transfer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9686182     DOI: 10.1590/s0100-879x1998000100010

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  14 in total

1.  An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.

Authors:  Angel A Oñate; Gabriel Donoso; Gustavo Moraga-Cid; Hugo Folch; Sandra Céspedes; Edilia Andrews
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  Interleukin-1 receptor-associated kinase 4 is essential for initial host control of Brucella abortus infection.

Authors:  Fernanda S Oliveira; Natália B Carvalho; Ana Paula M S Brandão; Marco Túlio R Gomes; Leonardo A de Almeida; Sérgio C Oliveira
Journal:  Infect Immun       Date:  2011-08-15       Impact factor: 3.441

3.  Subcellular fractions of Brucella ovis distinctively induce the production of interleukin-2, interleukin-4, and interferon-gamma in mice.

Authors:  E Salas-Téllez; A Núñez del Arco; V Tenorio; E Díaz-Aparicio; M de la Garza; F Suárez-Güemes
Journal:  Can J Vet Res       Date:  2005-01       Impact factor: 1.310

4.  A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice.

Authors:  Angel A Oñate; Sandra Céspedes; Alex Cabrera; Rodolfo Rivers; Andrés González; Carola Muñoz; Hugo Folch; Edilia Andrews
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

5.  TLR9 is required for MAPK/NF-κB activation but does not cooperate with TLR2 or TLR6 to induce host resistance to Brucella abortus.

Authors:  Marco Túlio Gomes; Priscila Carneiro Campos; Guilherme de Sousa Pereira; Daniella Castanheira Bartholomeu; Gary Splitter; Sergio Costa Oliveira
Journal:  J Leukoc Biol       Date:  2015-11-17       Impact factor: 4.962

6.  Use of S-[2,3-bispalmitoyiloxy-(2R)-propyl]-R-cysteinyl-amido-monomethoxy polyethylene glycol as an adjuvant improved protective immunity associated with a DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus in mice.

Authors:  Angello Retamal-Díaz; Roberto Riquelme-Neira; Darwin Sáez; Alejandra Rivera; Pablo Fernández; Alex Cabrera; Carlos A Guzmán; Angel Oñate
Journal:  Clin Vaccine Immunol       Date:  2014-08-27

7.  Immunological responses to recombinant cysteine synthase A of Brucella abortus in BALB/c mice.

Authors:  Shikha Jain; Prachiti Afley; Subodh Kumar
Journal:  World J Microbiol Biotechnol       Date:  2012-12-27       Impact factor: 3.312

8.  Early transcriptional responses of internalization defective Brucella abortus mutants in professional phagocytes, RAW 264.7.

Authors:  Seung Bin Cha; Won Jung Lee; Min Kyoung Shin; Myung Hwan Jung; Seung Won Shin; An Na Yoo; Jong Wan Kim; Han Sang Yoo
Journal:  BMC Genomics       Date:  2013-06-27       Impact factor: 3.969

9.  Nucleotide-binding oligomerization domain-1 and -2 play no role in controlling Brucella abortus infection in mice.

Authors:  Fernanda S Oliveira; Natalia B Carvalho; Dario S Zamboni; Sergio C Oliveira
Journal:  Clin Dev Immunol       Date:  2011-11-30

10.  Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.

Authors:  Jerome S Harms; Marina A Durward; Diogo M Magnani; Gary A Splitter
Journal:  J Immune Based Ther Vaccines       Date:  2009-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.